Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Irritable Bowel Syndrome, November 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 89 articles:
HTML format


 

Single Articles

  1. SAVIANO A, Petruzziello C, Zanza C, Candelli M, et al
    Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding.
    Rev Recent Clin Trials. 2023 Oct 26. doi: 10.2174/0115748871259008231006071656.
    PubMed    
    Abstract available

  2. HESSLER N, Kordowski A, Sasse J, Ahlemann G, et al
    Study protocol to investigate the efficacy of confocal laser endomicroscopy-based selective single-elimination diet over standard fivefold elimination diet in patients with endomicroscopically proven food intolerance: app-assisted, monocentric, double
    BMJ Open. 2023;13:e072024.
    PubMed    
    Abstract available

  3. YUAN S, Dan L, Zhang Y, Wu J, et al
    Gastrointestinal Diseases, Genetic Risk, and Incident Dementia: A Prospective Cohort Study in 352,463 Middle-Aged Adults.
    Am J Prev Med. 2023 Oct 31:S0749-3797(23)00433.
    PubMed    
    Abstract available

  4. ZHANG D, Tang Y, Bai X, Li D, et al
    Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews.
    Front Pharmacol. 2023;14:1264779.
    PubMed    
    Abstract available

  5. GARGARI G, Mantegazza G, Taverniti V, Gardana C, et al
    Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
    Gut Microbes. 2023;15:2274128.
    PubMed    
    Abstract available

  6. LENOVER MB, Shenk MK
    Evolutionary medicine approaches to chronic disease: The case of irritable bowel syndrome.
    Evol Anthropol. 2023 Nov 1. doi: 10.1002/evan.22010.
    PubMed    
    Abstract available

  7. YANG F, Wu Y, Hockey R, Doust J, et al
    Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management.
    Cell Rep Med. 2023 Oct 30:101250. doi: 10.1016/j.xcrm.2023.101250.
    PubMed    
    Abstract available

  8. COLGAN A, Digby K, Apekey T, Elborough-Whitehouse I, et al
    A dietitian led low FODMAP diet webinar: A pre-post study evaluating the impact on symptoms of Irritable Bowel Syndrome.
    J Hum Nutr Diet. 2023 Oct 31. doi: 10.1111/jhn.13262.
    PubMed    
    Abstract available

  9. CHANG JY
    Letter to the Editor: Survey-Based Analysis of Clinical Treatment Status of Irritable Bowel Syndrome in Korea: Suggestions for Future Research.
    J Korean Med Sci. 2023;38:e378.
    PubMed    


  10. MOUSAVI E, Hassanzadeh Keshteli A, Sehhati M, Vaez A, et al
    Exploring new subgroups for irritable bowel syndrome using a machine learning algorithm.
    Sci Rep. 2023;13:18483.
    PubMed    
    Abstract available

  11. VERAZA DI, Calderon G, Jansson-Knodell C, Aljaras R, et al
    A systematic review and meta-analysis of diet and nutrient intake in adults with irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Oct 27:e14698. doi: 10.1111/nmo.14698.
    PubMed    
    Abstract available

  12. DUDZINSKA E, Grabrucker AM, Kwiatkowski P, Sitarz R, et al
    The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome-Plant Metabolites in IBS Treatment.
    Pharmaceuticals (Basel). 2023;16:1405.
    PubMed    
    Abstract available

  13. NOURI M, Westrom B, Lavasani S
    Elevated Fecal Calprotectin Accompanied by Intestinal Neutrophil Infiltration and Goblet Cell Hyperplasia in a Murine Model of Multiple Sclerosis.
    Int J Mol Sci. 2023;24:15367.
    PubMed    
    Abstract available

  14. MOTATAIANU A, Serban G, Andone S
    The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
    Int J Mol Sci. 2023;24:15094.
    PubMed    
    Abstract available

  15. PARIPATI N, Nesi L, Sterrett JD, Dawud LM, et al
    Gut Microbiome and Lipidome Signatures in Irritable Bowel Syndrome Patients from a Low-Income, Food-Desert Area: A Pilot Study.
    Microorganisms. 2023;11:2503.
    PubMed    
    Abstract available

  16. GARCIA-MAZCORRO JF, Amieva-Balmori M, Triana-Romero A, Wilson B, et al
    Fecal Microbial Composition and Predicted Functional Profile in Irritable Bowel Syndrome Differ between Subtypes and Geographical Locations.
    Microorganisms. 2023;11:2493.
    PubMed    
    Abstract available

  17. MARTINELLI S, Nannini G, Cianchi F, Staderini F, et al
    Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments.
    Microorganisms. 2023;11:2407.
    PubMed    
    Abstract available

  18. NIKOLAKI MD, Kasti AN, Katsas K, Petsis K, et al
    The Low-FODMAP Diet, IBS, and BCFAs: Exploring the Positive, Negative, and Less Desirable Aspects-A Literature Review.
    Microorganisms. 2023;11:2387.
    PubMed    
    Abstract available

  19. NAPOLITANO M, Fasulo E, Ungaro F, Massimino L, et al
    Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.
    Microorganisms. 2023;11:2369.
    PubMed    
    Abstract available

  20. SONG SY, Jung YW, Shin W, Park M, et al
    Endometriosis-Related Chronic Pelvic Pain.
    Biomedicines. 2023;11:2868.
    PubMed    
    Abstract available

  21. TARAR ZI, Farooq U, Nawaz A, Gandhi M, et al
    Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database.
    Biomedicines. 2023;11:2594.
    PubMed    
    Abstract available

  22. CEREN AKGOR M, Vuralli D, Sucu DH, Gokce S, et al
    Distinct Food Triggers for Migraine, Medication Overuse Headache and Irritable Bowel Syndrome.
    J Clin Med. 2023;12:6488.
    PubMed    
    Abstract available

  23. POP D, Pop RS, Farcau D
    The Use of Fibers, Herbal Medicines and Spices in Children with Irritable Bowel Syndrome: A Narrative Review.
    Nutrients. 2023;15:4351.
    PubMed    
    Abstract available

  24. RYAN T, Daly E, Ryan L
    Exploring the Nutrition Strategies Employed by Ultra-Endurance Athletes to Alleviate Exercise-Induced Gastrointestinal Symptoms-A Systematic Review.
    Nutrients. 2023;15:4330.
    PubMed    
    Abstract available

  25. SANTACROCE G, Lenti MV, Abruzzese GM, Alunno G, et al
    Diagnostic delay in symptomatic uncomplicated diverticular disease: an Italian tertiary referral centre study.
    Intern Emerg Med. 2023 Oct 27. doi: 10.1007/s11739-023-03446.
    PubMed    
    Abstract available

  26. VARMA R, Feuerhak KJ, Mishra R, Chakraborty S, et al
    A randomized double-blind trial of clonidine and colesevelam for women with fecal incontinence.
    Neurogastroenterol Motil. 2023 Oct 27:e14697. doi: 10.1111/nmo.14697.
    PubMed    
    Abstract available

  27. JACOBSEN SA, Frostholm L, Buhmann CB, Petersen MW, et al
    Are Sexual Assaults Related to Functional Somatic Disorders? A Cross-Sectional Study.
    Int J Environ Res Public Health. 2023;20:6947.
    PubMed    
    Abstract available

  28. JIABAO W, Lishuang Z, Baihan N, Yajun YU, et al
    Efficacy and safety of Weichang' an pill combined with Western Medicine on gastrointestinal diseases: a systematic review and Meta-analysis.
    J Tradit Chin Med. 2023;43:1057-1067.
    PubMed    
    Abstract available

  29. PARK JH, Kang SH, Kim JS, Moon HS, et al
    Contribution of sex and gender roles to the incidence of post-infectious irritable bowel syndrome in a prospective study.
    Sci Rep. 2023;13:19467.
    PubMed    
    Abstract available

  30. BUSBY-WHITEHEAD J, Whitehead WE, Sperber AD, Palsson OS, et al
    The aging gut: Symptoms compatible with disorders of gut-brain interaction (DGBI) in older adults in the general population.
    J Am Geriatr Soc. 2023 Nov 9. doi: 10.1111/jgs.18679.
    PubMed    
    Abstract available

  31. PERETS TT, Huta Y, Ashorov O, Seef A, et al
    Comparing a New Flow Immune-Chromatography Fast Assay with a Random Access Semi-Automatic Chemiluminescent Immunoassay to Measure Fecal Calprotectin.
    Ann Clin Lab Sci. 2023;53:784-788.
    PubMed    
    Abstract available

  32. D T, Venkatesh MP
    Fecal Microbiota Transplantation: History, Procedure and Regulatory Considerations.
    Presse Med. 2023 Nov 7:104204. doi: 10.1016/j.lpm.2023.104204.
    PubMed    
    Abstract available

  33. ZHAO M, Hao Z, Li M, Xi H, et al
    Functional changes of default mode network and structural alterations of gray matter in patients with irritable bowel syndrome: a meta-analysis of whole-brain studies.
    Front Neurosci. 2023;17:1236069.
    PubMed    
    Abstract available

  34. JAZZAR Y, Shadid AM, Beidas T, Aldosari BM, et al
    Prurigo pigmentosa post-bariatric surgery: a case report.
    AME Case Rep. 2023;7:43.
    PubMed    
    Abstract available

  35. SCIUTO M, Catanzaro R
    Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases.
    Acta Microbiol Immunol Hung. 2023 Nov 8. doi: 10.1556/030.2023.02134.
    PubMed    
    Abstract available

  36. WU BY, Xu P, Cheng L, Wang QQ, et al
    Mucosa-associated microbiota dysbiosis in the terminal ileum correlates with bowel symptoms in diarrhea-predominant irritable bowel syndrome.
    Clin Transl Gastroenterol. 2023 Nov 8. doi: 10.14309/ctg.0000000000000658.
    PubMed    
    Abstract available

  37. PIOTROWICZ G, Rudnik AA, Bidzan M, Rydzewska G, et al
    Selected personality traits and emotional disorders of women diagnosed with gastrointestinal disease - a pilot study.
    Prz Gastroenterol. 2023;18:300-307.
    PubMed    
    Abstract available

  38. NEVEROVSKYI A, Shypulin V, Mikhnova N
    Translation and validation of the Ukrainian version of the visceral sensitivity index for patients with irritable bowel syndrome.
    Prz Gastroenterol. 2023;18:313-319.
    PubMed    
    Abstract available

  39. OLYAIEE A, Yadegar A, Mirsamadi ES, Sadeghi A, et al
    Profiling of the fecal microbiota and circulating microRNA-16 in IBS subjects with Blastocystis infection : a case-control study.
    Eur J Med Res. 2023;28:483.
    PubMed    
    Abstract available

  40. GUO X, Lei C, Liang H, An J, et al
    Chronic Sacral Nerve Stimulation Inhibits Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats Model.
    Neuromodulation. 2023 Nov 4:S1094-7159(23)00743.
    PubMed    
    Abstract available

  41. LI L, Cai Y, Yu C, Chen M, et al
    [Progress of researches on Blastocystis hominis infection among patients with inflammatory bowel disease and irritable bowel syndrome].
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2023;35:413-420.
    PubMed    
    Abstract available

  42. WEI Y, Fan Y, Huang S, Lv J, et al
    Baizhu shaoyao decoction restores the intestinal barrier and brain-gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1/FoxO3a.
    Phytomedicine. 2023;122:155163.
    PubMed    
    Abstract available

  43. ROTH B, Ohlsson B
    A starch- and sucrose-reduced diet may lead to improvement of intestinal and extraintestinal symptoms in more conditions than irritable bowel syndrome and congenital sucrase-isomaltase deficiency.
    Nutrition. 2023;117:112254.
    PubMed    
    Abstract available

  44. ORZECHOWSKA A, Maruszewska P, Galecka M, Hyland P, et al
    Emotional control in selected somatic and psychiatric diseases.
    BMC Psychiatry. 2023;23:802.
    PubMed    
    Abstract available

  45. PLASSE TF, Fathi R, Fehrmann C, McComsey GA, et al
    Upamostat: a serine protease inhibitor for antiviral, gastrointestinal and anticancer indications.
    Expert Opin Investig Drugs. 2023 Nov 16. doi: 10.1080/13543784.2023.2284385.
    PubMed    
    Abstract available

  46. MAS-OREA X, Rey L, Battut L, Bories C, et al
    Proenkephalin deletion in hematopoietic cells induces intestinal barrier failure resulting in clinical feature similarities with irritable bowel syndrome in mice.
    Commun Biol. 2023;6:1168.
    PubMed    
    Abstract available

  47. HERNANDEZ-VELASQUEZ DA, Rodriguez-Martinez E, Montoya-Meneses JD, Gonzalez-Ceballos JS, et al
    Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study.
    Drugs Real World Outcomes. 2023 Nov 15. doi: 10.1007/s40801-023-00395.
    PubMed    
    Abstract available

  48. KIM KW
    Comments on Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gut Liver. 2023;17:954-955.
    PubMed    


  49. LIU W, Fan X, Jian B, Wen D, et al
    The signaling pathway of hypoxia inducible factor in regulating gut homeostasis.
    Front Microbiol. 2023;14:1289102.
    PubMed    
    Abstract available

  50. BAART AM, Mensink M, Witteman BJM
    The impact of running on gastrointestinal symptoms in patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Nov 14:e14707. doi: 10.1111/nmo.14707.
    PubMed    
    Abstract available

  51. WU Q, Badu S, So SY, Treangen TJ, et al
    The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease.
    J Clin Invest. 2023 Nov 14:e170859. doi: 10.1172/JCI170859.
    PubMed    
    Abstract available

  52. RUSSO S, Chan K, Li L, Parise L, et al
    Stress-activated brain-gut circuits disrupt intestinal barrier integrity and social behaviour.
    Res Sq. 2023 Oct 27:rs.3.rs-3459170. doi: 10.21203/rs.3.rs-3459170.
    PubMed    
    Abstract available

  53. TORBICA A, Vujasinovic V, Radosavljevic M, Radivojevic G, et al
    FODMAPs-Unknowns for Consumers: First Survey in Serbia.
    Nutrients. 2023;15:4693.
    PubMed    
    Abstract available

  54. LINSALATA M, Riezzo G, Orlando A, D'Attoma B, et al
    The Role of Intestinal Barrier Function in Overweight Patients with IBS with Diarrhea Undergoing a Long-Term Low Fermentable Oligo-, Di-, and Monosaccharide and Polyol Diet.
    Nutrients. 2023;15:4683.
    PubMed    
    Abstract available

  55. BIANCO A, Russo F, Franco I, Riezzo G, et al
    Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise.
    J Clin Med. 2023;12:6786.
    PubMed    
    Abstract available

  56. VULPOI RA, Luca M, Ciobanu A, Olteanu A, et al
    The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management.
    Diagnostics (Basel). 2023;13:3336.
    PubMed    
    Abstract available

  57. FLOOD P, Hanrahan N, Nally K, Melgar S, et al
    Human intestinal organoids: modelling gastrointestinal physiology and immunopathology - current applications and limitations.
    Eur J Immunol. 2023 Nov 13:e2250248. doi: 10.1002/eji.202250248.
    PubMed    
    Abstract available

  58. GARCIA-ETXEBARRIA K, Gayoso L, Arzallus T, Montalvo I, et al
    A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants.
    Front Nutr. 2023;10:1268538.
    PubMed    
    Abstract available

  59. ZURCHER BF
    The Tibetan formula Cong zhi 6 in the ORL (ENT) practice: Experiences with laryngopharyngeal reflux (LPR).
    Complement Med Res. 2023 Nov 11. doi: 10.1159/000534212.
    PubMed    
    Abstract available

  60. KRIDIN K, Ludwig RJ
    Isotretinoin is not associated with inflammatory bowel disease even when compared to topical antibiotics and topical retinoids.
    J Am Acad Dermatol. 2023 Nov 9:S0190-9622(23)03184.
    PubMed    


  61. LIN CY, Yao CA
    Antibiotics used to treat acne may be associated with inflammatory bowel disease: response to Kridin et al.'s "Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study".
    J Am Acad Dermatol. 2023 Nov 9:S0190-9622(23)03183.
    PubMed    


  62. RAMIREZ ARANDA JM, Martinez Gutierrez CM, Fuentes Ramirez MM, Escobedo Rios MR, et al
    [Familial aggregation in Irritable Colon Syndrome in Mexican patients. A case-control study].
    Aten Primaria. 2023;56:102794.
    PubMed    
    Abstract available

  63. RAJINDRAJITH S, Hathagoda W, Ganewatte E, Devanarayana N, et al
    Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions.
    Expert Rev Gastroenterol Hepatol. 2023.
    PubMed    
    Abstract available

  64. ELMUNZER BJ, Palsson OS, Forbes N, Zakaria A, et al
    Prolonged gastrointestinal manifestations after recovery from COVID-19.
    Clin Gastroenterol Hepatol. 2023 Nov 21:S1542-3565(23)00947.
    PubMed    
    Abstract available

  65. ZHANG FC, Wei YX, Weng RX, Xu QY, et al
    Paraventricular thalamus-insular cortex circuit mediates colorectal visceral pain induced by neonatal colonic inflammation in mice.
    CNS Neurosci Ther. 2023 Nov 23. doi: 10.1111/cns.14534.
    PubMed    
    Abstract available

  66. BARBERIO B, Fairbrass KM, Gracie DJ, Ford AC, et al
    Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Neurogastroenterol Motil. 2023 Nov 22:e14713. doi: 10.1111/nmo.14713.
    PubMed    
    Abstract available

  67. SILVA JTC, Fonseca Neto OCLD
    Post-COVID-19 irritable bowel syndrome: an integrative review.
    Rev Col Bras Cir. 2023;50:e20233618.
    PubMed    
    Abstract available

  68. ALAM MJ, Chen JDZ
    Non-invasive neuromodulation: an emerging intervention for visceral pain in gastrointestinal disorders.
    Bioelectron Med. 2023;9:27.
    PubMed    
    Abstract available

  69. AHMED A, Dixit K, Singh A, Agarwal A, et al
    Sieving out non-celiac gluten sensitivity amongst patients with irritable bowel syndrome.
    Dig Liver Dis. 2023 Nov 18:S1590-8658(23)01003-4. doi: 10.1016/j.dld.2023.
    PubMed    
    Abstract available

  70. PAREKI G, Wozniak A, Abegunde AT
    Diagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists.
    Clin Med Res. 2023;21:129-135.
    PubMed    
    Abstract available

  71. ZHU Z, Yang XF, Yu HM, Chen PB, et al
    Effect of acupuncture on the expression of neuropeptides and related inflammatory factors in rats with diarrhea-predominant irritable bowel syndrome.
    Zhen Ci Yan Jiu. 2023;48:1142-1150.
    PubMed    
    Abstract available

  72. ZHOU XL, Wang H, Wu S, Li J, et al
    Comparison of the effects of moxibustion and acupuncture of combined "Biao-Ben" acupoints on intestinal sensitivity and autonomic nervous system function in rats with diarrhea-predominant irritable bowel syndrome.
    Zhen Ci Yan Jiu. 2023;48:1134-1141.
    PubMed    
    Abstract available

  73. WU CS, Chen TT, Liao SC, Huang WC, et al
    Clinical outcomes, medical costs, and medication usage patterns of different somatic symptom disorders and functional somatic syndromes: a population-based study in Taiwan.
    Psychol Med. 2023 Nov 20:1-9. doi: 10.1017/S0033291723003355.
    PubMed    
    Abstract available

  74. TAGHVAEINIA A, Karami M, Azizi A
    Comparison of the Effect of Dialectical Behavior Therapy, Acceptance and Commitment Therapy mindfulness-based Stress Reduction on Irritable Bowel Syndrome Symptoms, Quality of Life, Anxiety and Depression: A Pilot Randomized Controlled Trial.
    Psychiatr Q. 2023 Nov 17. doi: 10.1007/s11126-023-10058.
    PubMed    
    Abstract available

  75. CINDOGLU C, Uyanikoglu A, Sari S, Ozkutlu M, et al
    Thiol-disulfide homeostasis in irritable bowel syndrome.
    Eur Rev Med Pharmacol Sci. 2023;27:10569-10576.
    PubMed    
    Abstract available

  76. HERFINDAL AM, van Megen F, Gilde MKO, Valeur J, et al
    Effects of a low FODMAP diet on gut microbiota in individuals with treated celiac disease having persistent gastrointestinal symptoms - a randomized controlled trial.
    Br J Nutr. 2023 Jun 5:1-36. doi: 10.1017/S0007114523001253.
    PubMed    
    Abstract available

  77. EL-SALHY M, Gilja OH, Hatlebakk JG
    Letter: A step forward towards a standard FMT protocol for IBS.
    Aliment Pharmacol Ther. 2023;58:1115-1116.
    PubMed    


  78. LESMANA E, Grover M
    Editorial: Faecal microbiota transplantation in IBS-Moving closer or away from success?
    Aliment Pharmacol Ther. 2023;58:950-951.
    PubMed    


  79. SU Q, Yau YK, Ng SC
    Editorial: Faecal microbiota transplantation in IBS-Moving closer or away from success? Authors' reply.
    Aliment Pharmacol Ther. 2023;58:952-953.
    PubMed    


  80. DEVENNEY J, Hasan SS, Morris J, Whorwell PJ, et al
    Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
    Aliment Pharmacol Ther. 2023 Nov 5. doi: 10.1111/apt.17790.
    PubMed    
    Abstract available

  81. STAUDACHER HM, Mahoney S, Canale K, Opie RS, et al
    Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023 Nov 15. doi: 10.1111/apt.17791.
    PubMed    
    Abstract available

  82. ARNOLD MJ
    Medications for Irritable Bowel Syndrome: Guidelines From the AGA.
    Am Fam Physician. 2023;108:527-529.
    PubMed    


  83. D'SILVA A, Islam Z, Marshall DA, Vallance JK, et al
    Experiences of Irritable Bowel Syndrome Patients in a Virtual Yoga Program: Qualitative Findings from a Clinical Trial.
    Dig Dis Sci. 2023 Nov 1. doi: 10.1007/s10620-023-08125.
    PubMed    
    Abstract available

  84. KYODO R, Kudo T, Ito N, Tokita K, et al
    Modulation of Intestinal Motility in an Adolescent Rat Model of Irritable Bowel Syndrome.
    Digestion. 2023 Nov 14:1-8. doi: 10.1159/000534732.
    PubMed    
    Abstract available

  85. GARG P, Garg PK, Bhattacharya K
    Psyllium husk positively alters gut microbiota, decreases inflammation and has bowel-regulatory action, paving way for physiological management of irritable bowel syndrome (IBS).
    Gastroenterology. 2023 Nov 16:S0016-5085(23)05241.
    PubMed    


  86. HAREWOOD GC
    Cost impact of incorporating linaclotide into low-volume colonoscopy preparation.
    Gastrointest Endosc. 2023;98:876.
    PubMed    


  87. TUN HM, Peng Y, Massimino L, Sin ZY, et al
    Gut virome in inflammatory bowel disease and beyond.
    Gut. 2023 Nov 10:gutjnl-2023-330001. doi: 10.1136/gutjnl-2023-330001.
    PubMed    
    Abstract available

  88. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    PubMed    
    Abstract available

  89. GU Y, You Y, Guo G, Xie F, et al
    Effect of Prolong-life-with-nine-turn-method (Yan Nian Jiu Zhuan) Qigong on fatigue and gastrointestinal function in patients with chronic fatigue syndrome: Study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0287287.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;